Electromed, Inc. (ELMD) is a Medical - Devices company in the Healthcare sector, currently trading at $25.21. It has a SharesGrow Score of 81/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ELMD = $21.38 (-15.2% from the current price, the stock appears overvalued). Analyst consensus target is ELMD = $38 (+50.7% upside).
Valuation: ELMD trades at a trailing Price-to-Earnings (P/E) of 22.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.11.
Financials: revenue is $64M, +15.4%/yr average growth. Net income is $8M, growing at +48.8%/yr. Net profit margin is 11.8% (healthy). Gross margin is 78.1% (+2.6 pp trend).
Balance sheet: total debt is $198,000 against $43M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 4.31 (strong liquidity). Debt-to-assets is 0.4%. Total assets: $54M.
Analyst outlook: 4 / 4 analysts rate ELMD as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 74/100 (Pass), Growth 90/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 50/100 (Partial), Future 100/100 (Pass), Income 55/100 (Partial).
